跳至主要内容
临床试验/CTRI/2022/11/047692
CTRI/2022/11/047692尚未招募4 期

Comparison of therapeutic efficacy and safety of two concentrations of intra-lesional triamcinolone acetonide in patchy alopecia areata of the scalp: an open label randomized trial

I0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients of both sexes(males and females), aged >13 years with AA,
  • 2.Patients having AA on the scalp with <50% involvement.
  • 3.Patients who had not taken any form of treatment in the last 8 weeks.
  • 4.Patients who are willing to sign the written consent form before participating in the study

排除标准

  • 1.Patients aged <13 years
  • 2.Patients with alopecia totalis, alopecia universalis and ophiasis.
  • 3.Patients having skin diseases affecting the scalp.
  • 4.Patients with active infection at the local site and with keloidal tendency.
  • 5.Pregnant or lactating women or immuno-compromised patients or patients with bleeding or coagulation disorders

研究者

发起方
I

相似试验